Assessing the in vitro activity of ceftazidime/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope-Reference-Cited by-同舟云学术

Assessing the in vitro activity of ceftazidime/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope

Published:2018-11 Issue:5 Volume:52 Page:688-691
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Avery Lindsay M.,Nicolau David P.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference16 articles.

1. Application of “precision medicine” through the molecular characterization of extensively drug-resistant Klebsiella pneumoniae in a multivisceral transplant patient;Rosa;Clin Infect Dis,2017

2. Ceftazidime-avibactam and aztreonam, an interesting strategy to overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae and Pseudomonas aeruginosa;Davido;Antimicrob Agents Chemother,2017

3. Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection;Shaw;J Antimicrob Chemother,2017

4. Better tests, better care: improved diagnostics for infectious diseases;Caliendo;Clin Infect Dis,2013

5. Can ceftazidime-avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae?;Marshall;Antimicrob Agents Chemother,2017

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro and in vivo activity of ceftazidime/avibactam and aztreonam alone or in combination against mcr-9, serine- and metallo-β-lactamases–co-producing carbapenem-resistant Enterobacter cloacae complex;European Journal of Clinical Microbiology & Infectious Diseases;2024-05-03

2. Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections;Frontiers in Microbiology;2024-04-05

3. Carbapenem-resistant Klebsiella pneumoniae among hospitalized patients in Cape Town, South Africa: molecular epidemiology and characterization;JAC-Antimicrobial Resistance;2024-03-05

4. Use of Aztreonam Plus Ceftazidime/Avibactam Combination for In vitro Susceptibility Testing of CRO Isolates in a Tertiary Care Hospital – Our experience;Journal of Marine Medical Society;2024-02-29

5. Non-KPC Attributes of Newer β-lactam/β-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa;Clinical Infectious Diseases;2024-02-02